Literature DB >> 21704956

Effect of Gui-zhi-fu-ling-wan on hot flashes in young patients: a retrospective case series.

Ki-Ho Cho1, Young-Suk Kim, Woo-Sang Jung, Tae-Hun Kim.   

Abstract

Hot flashes are one of the main problems in postmenopausal patients. Hormone replacement therapy is the standard treatment for this vasomotor symptom, but long-term estrogen treatment can produce serious adverse effects such as higher risks of cardiovascular disease and breast cancer. For this reason, hormone replacement therapy may not be advisable for young patients. Gui-zhi-fu-ling-wan is an herbal decoction for hot flashes used in traditional Chinese medicine. We have extensive experience treating hot flashes in young women; this preliminary case series evaluates the effectiveness of Gui-zhi-fu-ling-wan for alleviating hot flashes in young patients. In this retrospective case series, we reviewed the medical records of outpatients who visited the Department of Cardiovascular and Neurologic Disease, Kyung Hee Oriental Medical Center for hot flashes from October 1, 2003 to October 1, 2008. Of the 60 cases, 37 met the inclusion criteria. Mean improvement in symptoms, as assessed using the visual analog scale, was 40.4 ± 28.5%; 51.3% of patients experienced a 50% improvement. According to the secondary analysis, the results of differential diagnosis of cold and hot syndrome and blood stasis syndrome did not affect scores. Only 2.7% of the patients reported adverse events. Our findings suggest that Gui-zhi-fu-ling-wan improves hot flashes in young patients in a relatively safe manner. However, rigorous clinical studies are needed to confirm these results.
Copyright © 2011 Korean Pharmacopuncture Institute. Published by .. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704956     DOI: 10.1016/S2005-2901(11)60019-8

Source DB:  PubMed          Journal:  J Acupunct Meridian Stud        ISSN: 2005-2901


  5 in total

1.  Efficacy and safety of Gyejibokryeong-hwan (GBH) in major depressive disorder: study protocol for multicentre randomised controlled trial.

Authors:  Yujin Choi; In Chul Jung; Ju Yeon Kim; Seung-Hun Cho; Yunna Kim; Sun-Yong Chung; Hui-Yong Kwak; Doo Suk Lee; Wonwoo Lee; In-Jeong Nam; Changsop Yang; Mi Young Lee
Journal:  Trials       Date:  2022-06-01       Impact factor: 2.728

2.  The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.

Authors:  Chi-Chen Lu; Mei-Yi Lin; Syue-Yi Chen; Cheng-Huang Shen; Lih-Geeng Chen; Hsiao-Yen Hsieh; Michael W Y Chan; Cheng-Da Hsu
Journal:  BMC Complement Altern Med       Date:  2013-02-23       Impact factor: 3.659

3.  Effect of Guizhifulingwan (Keishibukuryogan) on climacteric syndrome: study protocol for a randomized controlled pilot trial.

Authors:  Jung-Eun Kim; Junghyo Cho; Ojin Kwon; Ae-Ran Kim; Hyo-Ju Park; So-Young Jung; Joo-Hee Kim; Mikyung Kim; Hye-Yoon Lee; Jun-Hwan Lee
Journal:  Trials       Date:  2017-03-21       Impact factor: 2.279

Review 4.  A Review on the Mechanism and Application of Keishibukuryogan.

Authors:  Koichiro Tanaka; Koki Chiba; Kazuhiko Nara
Journal:  Front Nutr       Date:  2021-12-24

Review 5.  The Multiple Pharmacologic Functions and Mechanisms of Action of Guizhi Fuling Formulation.

Authors:  Jie Gao; Jianmei Yang; Zhiyuan Lu; Xianwen Dong; Ying Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-29       Impact factor: 2.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.